MetaCap

MBX Biosciences Inc. Company Profile

NASDAQ: MBXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

49.55-3.86 (-7.23%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MBX Biosciences at a glance

MBX Biosciences Inc. (NASDAQ: MBX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Carmel, IN. MBX Biosciences is led by Mr. Steven L. Hoerter and employs about 63 people. The company's shares have traded publicly since 2024.

At a market capitalization of $2.46 billion, it is considered a mid-cap company. Its SEC Central Index Key (CIK) is 0001776111, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does MBX Biosciences do?

MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is Canvuparatide (MBX 2109), a parathyroid hormone peptide prodrug, which is in Phase 3 clinical trial for the treatment of chronic hypoparathyroidism. The company is also developing Imapextide (MBX 1416), a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 2 clinical trial a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. In addition, it is developing MBX 4291, a lead obesity product candidate, which is in investigational new drug-enabling studies for the treatment of obesity and co-morbidities. The company was founded in 2018 and is based in Carmel, Indiana.

Business description based on the company's public filings.

Company information

Legal name
MBX Biosciences Inc.
Ticker
NASDAQ: MBX
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Steven L. Hoerter
Employees
63
Headquarters
11711 North Meridian Street, Carmel, IN, United States
Phone
317 659 0200
Website
mbxbio.com
IPO year
2024
SEC CIK
0001776111
Latest annual report
10-K · Mar 12, 2026

Companies similar to MBX Biosciences

MBX peer companies
CompanyPrice% ChgMarket capCompare
IDYAIDEAYA Biosciences Inc.25.56-2.33%$2.47Bvs MBX
XNCRXencor Inc.33.26-2.21%$2.50Bvs MBX
PBHPrestige Consumer Healthcare Inc.49.63+0.06%$2.35Bvs MBX
HCMHUTCHMED (China) Limited ADR13.22-1.71%$2.30Bvs MBX
ZLABZai Lab Limited ADR21.03-4.06%$2.63Bvs MBX
RCUSArcus Biosciences Inc.15.62-1.01%$2.25Bvs MBX
PHVSPharvaris N.V.31.28-1.20%$2.21Bvs MBX
PRGOPerrigo Company plc15.94-0.62%$2.21Bvs MBX

Related